Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 1:08 AM
NCT ID:
NCT00592293
Eligibility Criteria:
Inclusion Criteria:
* Biopsy proven Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) or bone sarcoma
* Less than or equal to 30 years of age
* Patients must have been treated with a standardly accepted chemotherapy regimen if chemotherapy is indicated
* Patients must be willing to receive follow-up care for a minimum of five years after treatment at MGH and annual visits unless it is too difficult to return to MGH for follow-up care. In that event, the patient or guardian must be willing to have their outside medical information released in order to track the results of treatment
* They or their legal guardian must give their informed consent
* Timing of radiation may be according to concurrent protocol
Exclusion Criteria:
* Co-morbidities that would make the use of radiation too toxic to deliver safely, such as serious local injury of collagen vascular disease
* Patients who are pregnant
* Previous treatment with radiation therapy
* Concurrent adriamycin or gemcitabine chemotherapy is planned, unless on a concurrent protocol
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
30 Years
Study:
NCT00592293
Study Brief:
Protocol Section:
NCT00592293